The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Chemical Compound Review

Dacogen     4-amino-1-[(2R,4S,5R)-4- hydroxy-5...

Synonyms: Decitabine, AzadC, Dezocitidine, SureCN4006, PubChem19115, ...
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Decitabine


High impact information on Decitabine


Chemical compound and disease context of Decitabine


Biological context of Decitabine


Anatomical context of Decitabine


Associations of Decitabine with other chemical compounds


Gene context of Decitabine


Analytical, diagnostic and therapeutic context of Decitabine


  1. Inactivation of the apoptosis effector Apaf-1 in malignant melanoma. Soengas, M.S., Capodieci, P., Polsky, D., Mora, J., Esteller, M., Opitz-Araya, X., McCombie, R., Herman, J.G., Gerald, W.L., Lazebnik, Y.A., Cordón-Cardó, C., Lowe, S.W. Nature (2001) [Pubmed]
  2. Effects of 5-aza-2'-deoxycytidine on matrix metalloproteinase expression and pancreatic cancer cell invasiveness. Sato, N., Maehara, N., Su, G.H., Goggins, M. J. Natl. Cancer Inst. (2003) [Pubmed]
  3. Toxicity of 5-aza-2'-deoxycytidine to mammalian cells is mediated primarily by covalent trapping of DNA methyltransferase rather than DNA demethylation. Jüttermann, R., Li, E., Jaenisch, R. Proc. Natl. Acad. Sci. U.S.A. (1994) [Pubmed]
  4. MYO18B, a candidate tumor suppressor gene at chromosome 22q12.1, deleted, mutated, and methylated in human lung cancer. Nishioka, M., Kohno, T., Tani, M., Yanaihara, N., Tomizawa, Y., Otsuka, A., Sasaki, S., Kobayashi, K., Niki, T., Maeshima, A., Sekido, Y., Minna, J.D., Sone, S., Yokota, J. Proc. Natl. Acad. Sci. U.S.A. (2002) [Pubmed]
  5. High frequency of hypermethylation at the 14-3-3 sigma locus leads to gene silencing in breast cancer. Ferguson, A.T., Evron, E., Umbricht, C.B., Pandita, T.K., Chan, T.A., Hermeking, H., Marks, J.R., Lambers, A.R., Futreal, P.A., Stampfer, M.R., Sukumar, S. Proc. Natl. Acad. Sci. U.S.A. (2000) [Pubmed]
  6. ROS1, a repressor of transcriptional gene silencing in Arabidopsis, encodes a DNA glycosylase/lyase. Gong, Z., Morales-Ruiz, T., Ariza, R.R., Roldán-Arjona, T., David, L., Zhu, J.K. Cell (2002) [Pubmed]
  7. Chloroplast DNA methylation and inheritance in Chlamydomonas. Umen, J.G., Goodenough, U.W. Genes Dev. (2001) [Pubmed]
  8. DNA methylation maintains allele-specific KIR gene expression in human natural killer cells. Chan, H.W., Kurago, Z.B., Stewart, C.A., Wilson, M.J., Martin, M.P., Mace, B.E., Carrington, M., Trowsdale, J., Lutz, C.T. J. Exp. Med. (2003) [Pubmed]
  9. The IL-12Rbeta2 gene functions as a tumor suppressor in human B cell malignancies. Airoldi, I., Di Carlo, E., Banelli, B., Moserle, L., Cocco, C., Pezzolo, A., Sorrentino, C., Rossi, E., Romani, M., Amadori, A., Pistoia, V. J. Clin. Invest. (2004) [Pubmed]
  10. Inhibition of DNA methylation and reactivation of silenced genes by zebularine. Cheng, J.C., Matsen, C.B., Gonzales, F.A., Ye, W., Greer, S., Marquez, V.E., Jones, P.A., Selker, E.U. J. Natl. Cancer Inst. (2003) [Pubmed]
  11. Maintenance of elevated fetal hemoglobin levels by decitabine during dose interval treatment of sickle cell anemia. DeSimone, J., Koshy, M., Dorn, L., Lavelle, D., Bressler, L., Molokie, R., Talischy, N. Blood (2002) [Pubmed]
  12. Frequent hypomethylation of multiple genes overexpressed in pancreatic ductal adenocarcinoma. Sato, N., Maitra, A., Fukushima, N., van Heek, N.T., Matsubayashi, H., Iacobuzio-Donahue, C.A., Rosty, C., Goggins, M. Cancer Res. (2003) [Pubmed]
  13. Characterization of DNA demethylation effects induced by 5-Aza-2'-deoxycytidine in patients with myelodysplastic syndrome. Mund, C., Hackanson, B., Stresemann, C., Lübbert, M., Lyko, F. Cancer Res. (2005) [Pubmed]
  14. Hepatocyte growth factor activator inhibitor 2/placental bikunin (HAI-2/PB) gene is frequently hypermethylated in human hepatocellular carcinoma. Fukai, K., Yokosuka, O., Chiba, T., Hirasawa, Y., Tada, M., Imazeki, F., Kataoka, H., Saisho, H. Cancer Res. (2003) [Pubmed]
  15. Immunological characteristics of immunogenic variants induced in the MCA-F murine fibrosarcoma using 1-methyl-3-nitro-1-nitrosoguanidine, 5-aza-2'-deoxycytidine, or ultraviolet radiation. Simcik, W., Frost, P., LeGrue, S.J. Cancer Res. (1989) [Pubmed]
  16. Promoter methylation and silencing of the retinoic acid receptor-beta gene in lung carcinomas. Virmani, A.K., Rathi, A., Zöchbauer-Müller, S., Sacchi, N., Fukuyama, Y., Bryant, D., Maitra, A., Heda, S., Fong, K.M., Thunnissen, F., Minna, J.D., Gazdar, A.F. J. Natl. Cancer Inst. (2000) [Pubmed]
  17. Progressive stages of "transdifferentiation" from epidermal to mesenchymal phenotype induced by MyoD1 transfection, 5-aza-2'-deoxycytidine treatment, and selection for reduced cell attachment in the human keratinocyte line HaCaT. Boukamp, P., Chen, J., Gonzales, F., Jones, P.A., Fusenig, N.E. J. Cell Biol. (1992) [Pubmed]
  18. Mutagenicity of 5-aza-2'-deoxycytidine is mediated by the mammalian DNA methyltransferase. Jackson-Grusby, L., Laird, P.W., Magge, S.N., Moeller, B.J., Jaenisch, R. Proc. Natl. Acad. Sci. U.S.A. (1997) [Pubmed]
  19. Cell cycle-specific reactivation of an inactive X-chromosome locus by 5-azadeoxycytidine. Jones, P.A., Taylor, S.M., Mohandas, T., Shapiro, L.J. Proc. Natl. Acad. Sci. U.S.A. (1982) [Pubmed]
  20. Reactivation of XIST in normal fibroblasts and a somatic cell hybrid: abnormal localization of XIST RNA in hybrid cells. Hansen, R.S., Canfield, T.K., Stanek, A.M., Keitges, E.A., Gartler, S.M. Proc. Natl. Acad. Sci. U.S.A. (1998) [Pubmed]
  21. Depression of DNA synthesis in mouse spleen after treatment with 5-aza-2'-deoxycytidine. Cihák, A., Veselý, J. J. Natl. Cancer Inst. (1979) [Pubmed]
  22. The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation. De Smet, C., De Backer, O., Faraoni, I., Lurquin, C., Brasseur, F., Boon, T. Proc. Natl. Acad. Sci. U.S.A. (1996) [Pubmed]
  23. Demethylation of a hypermethylated P15/INK4B gene in patients with myelodysplastic syndrome by 5-Aza-2'-deoxycytidine (decitabine) treatment. Daskalakis, M., Nguyen, T.T., Nguyen, C., Guldberg, P., Köhler, G., Wijermans, P., Jones, P.A., Lübbert, M. Blood (2002) [Pubmed]
  24. JunB gene expression is inactivated by methylation in chronic myeloid leukemia. Yang, M.Y., Liu, T.C., Chang, J.G., Lin, P.M., Lin, S.F. Blood (2003) [Pubmed]
  25. Epigenetic silencing of RNA polymerase I transcription: a role for DNA methylation and histone modification in nucleolar dominance. Chen, Z.J., Pikaard, C.S. Genes Dev. (1997) [Pubmed]
  26. Continuous zebularine treatment effectively sustains demethylation in human bladder cancer cells. Cheng, J.C., Weisenberger, D.J., Gonzales, F.A., Liang, G., Xu, G.L., Hu, Y.G., Marquez, V.E., Jones, P.A. Mol. Cell. Biol. (2004) [Pubmed]
  27. Transfection of wild-type deoxycytidine kinase (dck) cDNA into an AraC- and DAC-resistant rat leukemic cell line of clonal origin fully restores drug sensitivity. Stegmann, A.P., Honders, W.H., Willemze, R., Ruiz van Haperen, V.W., Landegent, J.E. Blood (1995) [Pubmed]
  28. Aberrant Promoter Methylation of the ABCG2 Gene in Renal Carcinoma. To, K.K., Zhan, Z., Bates, S.E. Mol. Cell. Biol. (2006) [Pubmed]
  29. DNA methylation analysis of the promoter region of the human telomerase reverse transcriptase (hTERT) gene. Devereux, T.R., Horikawa, I., Anna, C.H., Annab, L.A., Afshari, C.A., Barrett, J.C. Cancer Res. (1999) [Pubmed]
  30. Increased CDA expression/activity in males contributes to decreased cytidine analog half-life and likely contributes to worse outcomes with 5-azacytidine or decitabine therapy. Mahfouz, R.Z., Jankowska, A., Ebrahem, Q., Gu, X., Visconte, V., Tabarroki, A., Terse, P., Covey, J., Chan, K., Ling, Y., Engelke, K.J., Sekeres, M.A., Tiu, R., Maciejewski, J., Radivoyevitch, T., Saunthararajah, Y. Clin. Cancer Res. (2013) [Pubmed]
  31. HLA-G gene repression is reversed by demethylation. Moreau, P., Mouillot, G., Rousseau, P., Marcou, C., Dausset, J., Carosella, E.D. Proc. Natl. Acad. Sci. U.S.A. (2003) [Pubmed]
  32. Loss of CDX1 expression in colorectal carcinoma: promoter methylation, mutation, and loss of heterozygosity analyses of 37 cell lines. Wong, N.A., Britton, M.P., Choi, G.S., Stanton, T.K., Bicknell, D.C., Wilding, J.L., Bodmer, W.F. Proc. Natl. Acad. Sci. U.S.A. (2004) [Pubmed]
  33. Endogenous assays of DNA methyltransferases: Evidence for differential activities of DNMT1, DNMT2, and DNMT3 in mammalian cells in vivo. Liu, K., Wang, Y.F., Cantemir, C., Muller, M.T. Mol. Cell. Biol. (2003) [Pubmed]
  34. The human ARF cell cycle regulatory gene promoter is a CpG island which can be silenced by DNA methylation and down-regulated by wild-type p53. Robertson, K.D., Jones, P.A. Mol. Cell. Biol. (1998) [Pubmed]
  35. Association of acetylated histones with paternally expressed genes in the Prader--Willi deletion region. Fulmer-Smentek, S.B., Francke, U. Hum. Mol. Genet. (2001) [Pubmed]
  36. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Herman, J.G., Latif, F., Weng, Y., Lerman, M.I., Zbar, B., Liu, S., Samid, D., Duan, D.S., Gnarra, J.R., Linehan, W.M. Proc. Natl. Acad. Sci. U.S.A. (1994) [Pubmed]
  37. 5-Aza-2'-deoxycytidine induces terminal differentiation of leukemic blasts from patients with acute myeloid leukemias. Pinto, A., Attadia, V., Fusco, A., Ferrara, F., Spada, O.A., Di Fiore, P.P. Blood (1984) [Pubmed]
WikiGenes - Universities